Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients.

MLA

Zuffa, Elisa, et al. “Revealing Very Small FLT3 ITD Mutated Clones by Ultra-Deep Sequencing Analysis Has Important Clinical Implications in AML Patients.” Oncotarget, vol. 6, no. 31, Oct. 2015, pp. 31284–94. EBSCOhost, https://doi.org/10.18632/oncotarget.5161.

APA

Zuffa, E., Franchini, E., Papayannidis, C., Baldazzi, C., Simonetti, G., Testoni, N., Abbenante, M. C., Paolini, S., Sartor, C., Parisi, S., Marconi, G., Cattina, F., Bochicchio, M. T., Venturi, C., Ottaviani, E., Cavo, M., & Martinelli, G. (2015). Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients. Oncotarget, 6(31), 31284–31294. https://doi.org/10.18632/oncotarget.5161

Chicago

Zuffa, Elisa, Eugenia Franchini, Cristina Papayannidis, Carmen Baldazzi, Giorgia Simonetti, Nicoletta Testoni, Maria Chiara Abbenante, et al. 2015. “Revealing Very Small FLT3 ITD Mutated Clones by Ultra-Deep Sequencing Analysis Has Important Clinical Implications in AML Patients.” Oncotarget 6 (31): 31284–94. doi:10.18632/oncotarget.5161.